KALA BIO, Inc. Common Stock(KALA)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

KALA iron condor setups KALA expected move KALA IV rank history

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Snapshot
Info
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834)
Exchange
XNAS
Market Cap
$0.0B

Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pig…

Price History
Seasonality
MonthAvg ReturnYears of Data
Jan +0.78% 9
Feb -8.75% 9
Mar +15.84% 9
Apr -13.09% 9
May -16.56% 9
Jun +1.32% 9
Jul +0.19% 9
Aug +4.97% 9
Sep -25.18% 9
Oct -22.08% 9
Nov +2.94% 9
Dec +55.16% 9
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $2.41
SMA 50: $5.24
SMA 200: $110.81
Current: $2.63
EMA 12: $2.46
EMA 26: $3.25
MACD: -0.7916 | Signal: 0.2776
BEARISH
ADX (14): 43.36
STRONG TREND
+DI: 16.63
−DI: 23.32
Momentum Oscillators
RSI (14): 36.40
NEUTRAL
Stoch %K: 65.02
Stoch %D: 53.70
Williams %R: -31.03
Volume & Volatility
BB Upper: $2.83
BB Lower: $1.99
NEUTRAL
OBV: 9,552,551
Vol SMA 20: 92,833
Vol ROC: 220.77%
ATR: $0.46
True Range: $0.43
HV 20: 98.4%
HV 30: 138.8%
HV 60: 123.1%
Data Summary
Data Points: 500
Last Updated: 2026-06-13T13:41:36.747000
Date Range: 2024-06-14T00:00:00 – 2026-06-12T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Options Activity
Loading options activity...
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Volatility Surface

Enter a ticker to render the implied volatility surface.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
2.13
Correlation (SPY)
16.1%
R²
0.03
Ann. Volatility
162.8%
SPY Volatility
12.3%

High volatility - stock moves more than market

Beta & Alpha Over Time
Institutional Ownership (13F)
Latest filings — 2026-03-31

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

29 filers1,698,575 shares$284.71K value
# Filer Shares Value % of Total % of Float Period
1 RENAISSANCE TECHNOLOGIES LLC 417,517 $72.27K 25.38% — 2026-03-31
2 VANGUARD GROUP INC Custodian 91,009 $50.60K 17.77% — 2025-12-31
3 CITADEL ADVISORS LLC Custodian 281,650 $48.75K 17.12% — 2026-03-31
4 GEODE CAPITAL MANAGEMENT, LLC Custodian 261,061 $45.19K 15.87% — 2026-03-31
5 ADAR1 Capital Management, LLC 141,480 $24.49K 8.60% — 2026-03-31
6 UBS Group AG Custodian 66,871 $11.57K 4.06% — 2026-03-31
7 JANE STREET GROUP, LLC Custodian 36,000 $6.23K 2.19% — 2026-03-31
8 JPMORGAN CHASE & CO Custodian 30,017 $5.13K 1.80% — 2026-03-31
9 STATE STREET CORP 28,576 $4.95K 1.74% — 2026-03-31
10 Grant Private Wealth Management Inc 20,000 $3.46K 1.22% — 2026-03-31
11 LPL Financial LLC Custodian 17,229 $2.98K 1.05% — 2026-03-31
12 GOLDMAN SACHS GROUP INC Custodian 14,048 $2.43K 0.85% — 2026-03-31
13 StoneX Group Inc. 12,984 $2.25K 0.79% — 2026-03-31
14 NORTHERN TRUST CORP Custodian 11,524 $2.00K 0.70% — 2026-03-31
15 BlackRock, Inc. Custodian 10,809 $1.87K 0.66% — 2026-03-31
16 MORGAN STANLEY Custodian 607 $338 0.12% — 2025-12-31
17 MAI Capital Management Custodian 300 $52 0.02% — 2026-03-31
18 HARBOUR INVESTMENTS, INC. 150 $26 <0.01% — 2026-03-31
19 Cheviot Value Management, LLC 153 $26 <0.01% — 2026-03-31
20 Virtu Financial LLC 152,197 $26 <0.01% — 2026-03-31
21 Steward Partners Investment Advisory, LLC 120 $21 <0.01% — 2026-03-31
22 INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 110 $18 <0.01% — 2026-03-31
23 GSA CAPITAL PARTNERS LLP 84,470 $15 <0.01% — 2026-03-31
24 Legacy Wealth Managment, LLC/ID 25 $5 <0.01% — 2026-03-31
25 Greenwich Wealth Management LLC 18,393 $3 <0.01% — 2026-03-31
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period
Insider Activity
Latest: 2025-12-22
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2025-12-22 David E. Lazar Chief Executive Officer Other (J) — — EDGAR
2025-11-26 David E. Lazar Chief Executive Officer Award (A) — — EDGAR
2025-10-24 Romulus K Brazzell SEE REMARKS Sell (S) −46,748 $0.83 -$38.8K EDGAR
2025-10-24 Mark T Iwicki Director Sell (S) −154,894 $0.81 -$125.5K EDGAR
2025-10-24 Darius Kharabi CHIEF BUSINESS OFFICER Sell (S) −20,806 $0.83 -$17.3K EDGAR
2025-10-24 Mary Reumuth CHIEF FINANCIAL OFFICER Sell (S) −33,197 $0.83 -$27.5K EDGAR
2025-10-24 Todd Bazemore Director Sell (S) −47,768 $0.83 -$39.6K EDGAR
2025-10-02 BAKER BROS. ADVISORS LP Sell (S) −2,921,632 $1.45 -$4.23M EDGAR
2025-09-02 Todd Bazemore SEE REMARKS Grant (A) +180,000 opt — EDGAR
2025-06-26 Darius Kharabi CHIEF BUSINESS OFFICER Sell (S) −4,511 $4.01 -$18.1K EDGAR
2025-06-26 Romulus K Brazzell SEE REMARKS Sell (S) −5,251 $4.01 -$21.1K EDGAR
2025-06-26 Mary Reumuth CHIEF FINANCIAL OFFICER Sell (S) −3,631 $4.01 -$14.6K EDGAR
2025-06-26 Mark T Iwicki Director Sell (S) −13,227 $4.01 -$53.0K EDGAR
2025-06-26 Todd Bazemore SEE REMARKS Sell (S) −4,058 $4.01 -$16.3K EDGAR
2025-06-17 Howard B Rosen Director Award (A) +2,450 — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
30 insiders · @ $2.63
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Rajeev M. Shah Director 10,914,613 $28.71M $78.00M 8 2021-06-21
2 RA Capital Healthcare Fund LP Director 10,874,613 $28.60M $150.00M 1 2020-03-13
3 RA CAPITAL MANAGEMENT, L.P. Director 7,039,613 $18.51M $16.58M 4 2022-05-26
4 Peter Kolchinsky Director 4,537,478 $11.93M $60.00M 1 2018-10-05
5 OrbiMed Capital GP VI LLC 10%+ Owner 3,447,840 $9.07M $13.52M 4 2018-02-12
6 ORBIMED ADVISORS LLC 10%+ Owner 3,362,160 $8.84M $18.52M 2 2018-02-02
7 Gregory Grunberg Director 2,917,006 $7.67M $28.22M 8 2021-06-21
8 SAMUEL D ISALY 10%+ Owner 2,375,279 $6.25M $14.37M 1 2017-07-27
9 PATRICK G ENRIGHT 10%+ Owner 2,055,946 $5.41M $12.90M 1 2017-07-27
10 ROBERT I TEPPER Director 1,621,092 $4.26M $0 2 2017-07-26
11 Hadley Harbor Master Investors (Cayman) L.P. 10%+ Owner 888,894 $2.34M $0 1 2017-07-25
12 CAXTON CORP 10%+ Owner 548,755 $1.44M $9.68M 1 2017-07-21
13 CDK ASSOCIATES, L.L.C. 10%+ Owner 548,755 $1.44M $9.68M 1 2017-07-21
14 Bruce Kovner 10%+ Owner 215,000 $565.5K $9.68M 1 2017-07-20
15 Hongming Chen CHIEF SCIENTIFIC OFFICER 204,515 $537.9K -$100.3K 14 2021-10-28
16 Mark S. Blumenkranz Director 181,545 $477.5K $0 5 2024-06-12
17 JULIAN BAKER 10%+ Owner 118,496 $311.6K $8.00M 1 2024-12-31
18 Mark T Iwicki Director 103,540 $272.3K -$488.3K 25 2025-10-24
19 Eric Trachtenberg SEE REMARKS 69,293 $182.2K -$47.1K 18 2024-01-05
20 BAKER BROS. ADVISORS LP 46,480 $122.2K -$4.23M 1 2025-10-02
21 Robert Bradley Paull Director 42,361 $111.4K $0 8 2022-06-17
22 Darius Kharabi CHIEF BUSINESS OFFICER 41,760 $109.8K -$88.7K 12 2025-10-24
23 Romulus K Brazzell SEE REMARKS 35,952 $94.6K -$191.4K 26 2025-10-24
24 Todd Bazemore SEE REMARKS 35,933 $94.5K -$118.5K 27 2025-10-24
25 Mary Reumuth CHIEF FINANCIAL OFFICER 28,906 $76.0K -$143.5K 24 2025-10-24
26 ANDREW I KOVEN Director 16,972 $44.6K $0 10 2025-06-17
27 Howard B Rosen Director 16,502 $43.4K $27.1K 12 2025-06-17
28 GREGORY D PERRY Director 13,344 $35.1K $0 9 2025-06-17
29 C. Daniel Myers Director 10,374 $27.3K $0 6 2025-06-17
30 Marjan Farid Director 10,242 $26.9K $0 5 2025-06-17
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.